???global.info.a_carregar???
I am graduated in Biochemistry (MSc), from the University of Beira Interior, in 2008. In 2010, I moved to the Netherlands to the group of Dr. Tom van der Pol, at the Center for Experimental and Molecular Medicine (Amsterdam Medical Center, AMC). During that period I acquired skills/knowledge in Infection, Immunity and Inflammation. In 2011, I started functions as a Research Technician in the group of Dr. Ronald Stam, at Pediatric Oncology/Hematology department, Erasmus Medical Center (Rotterdam, the Netherlands). There I participated and contributed for the successful completion of several projects, such as: i) Unravelling drug resistance in Infant Acute Lymphoblastic Leukaemia (ALL); ii) Role of Epigenetics in Infant ALL; iii) Role of Bone-Marrow niche in MLL-ALL using in vivo xenotransplantations models. In 2016, I moved together with the entire team of Dr. Stam to the Princess Maxima Center, Center for Pediatric Oncology (Utrecht, the Netherlands). During that time, while working as Senior Research Technician I was enrolled on the project: High-Throughput screening of Epigenetic-based drugs for the treatment of high risk Leukemias. As Research Assistant, I contributed directly to the different projects running in the team by planning and executing experiments, analysing and reporting data, working closely with PhD students and post-doctoral fellows. In 2018, I joined the team of Dr. Hugo Fernandes and Dr. Lino Ferreira, group of Biomaterials and Stem Cell-based Therapies, at the Biocant/CNC (Cantanhede, Portugal). My current research focuses on the study of GLP-1 receptor expression and beta-cell mass in type 2 diabetes patients. In 2019, I was awarded with a PhD fellowship from FCT to study the Extracellular Vesicles in Diabetes. My research achievements has been published in international peer-reviewed journal, such as Leukemia, Haematologica, Oncotarget, European Journal of Cancer, Immunobiology, the Journal of Biological Chemistry and Clinical Biochemistry.
Identificação

Identificação pessoal

Nome completo
Sandra Sofia Mimoso Pinhanços

Nomes de citação

  • Pinhanços, SS or Pinhanços, SM

Identificadores de autor

Ciência ID
C814-42E1-86D8
ORCID iD
0000-0002-6748-5554
Google Scholar ID
tv40oQUAAAAJ

Endereços de correio eletrónico

  • sandra.sofia.m@gmail.com (Profissional)
  • sandra.sofia.m@uc-biotech.pt (Profissional)

Telefones

Telefone
  • 231249170 (Profissional)
  • 231407377 (Pessoal)
Telemóvel
  • 934121400 (Pessoal)

Moradas

  • UC-Biotech, Nucleo 4, Lote8, 3061-197 , Cantanhede, Cantanhede, Portugal (Profissional)
  • Avenida do Brasil, lote 8, 3F, 3060-125, Cantanhede, Cantanhede, Portugal (Pessoal)

Websites

  • https://www.researchgate.net/profile/Sandra_Sofia_Mimoso_Pinhancos2 (Rede social)
  • www.linkedin.com/in/sandra-sofia-mimoso-pinhancos-073542149 (Profissional)
  • http://erachair.uc-biotech.pt/ (Profissional)

Domínios de atuação

  • Ciências Médicas e da Saúde - Medicina Clínica - Endocrinologia e Metabolismo
  • Ciências da Engenharia e Tecnologias - Outras Ciências da Engenharia e Tecnologias

Idiomas

Idioma Conversação Leitura Escrita Compreensão Peer-review
Português (Idioma materno)
Espanhol; Castelhano Utilizador independente (B1) Utilizador independente (B1) Utilizador elementar (A1) Utilizador independente (B1)
Inglês Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1) Utilizador proficiente (C1)
Holandês Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1) Utilizador elementar (A1)
Formação
Grau Classificação
2020/03/01 - 2024/03/01
Em curso
PhD Program in Experimental Biology and Biomedicine (Doutoramento)
Center for Neurosciences and Cell Biology, University of Coimbra, Portugal
"Extracellular vesicles in Diabetes" (TESE/DISSERTAÇÃO)
2020/02/17 - 2020/02/21
Concluído
Communication in Science (Outros)
Center for Neurosciences and Cell Biology, University of Coimbra, Portugal
2018/05 - 2018/05
Concluído
Programming in R (basic Course) (Graduado)
Erasmus MC, Países Baixos
2017 - 2017
Concluído
Indesign CS6 (Graduado)
Erasmus MC, Países Baixos
2016/06/23 - 2016/06/24
Concluído
Survival Analysis Course (from basic statistics to Kaplan-Meier plots) (Graduado)
Erasmus MC, Países Baixos
2016/04/05 - 2016/04/05
Concluído
Photoshop & Illustrator CS5 workshop (Graduado)
Erasmus MC, Países Baixos
2015/11/02 - 2015/11/06
Concluído
Course Biomedical Research Techniques ((primers and probes, methylation, siRNA, Flow Cytometry, Microscopy) (Graduado)
Especialização em Research Techniques
Erasmus MC, Países Baixos
2014/06/10 - 2014/06/12
Concluído
Workshop Molecular Aspects of Hematological Malignancies (Graduado)
Erasmus MC, Países Baixos
2013/09/24 - 2013/09/27
Concluído
Translational Animal Imaging (3D Fluorescence and Bioluminescence (IVIS), Fluorescence Molecular Tomography (FMT), µCT) (Graduado)
Erasmus MC, Países Baixos
2013/04/08 - 2013/04/26
Concluído
Course Animal Experimentation Article 9 (FELASA C) (Graduado)
Especialização em Experimentação Animal
Erasmus MC, Países Baixos
2007/09 - 2008/09
Concluído
Bioquímica (Mestrado)
Especialização em Bioquímica
Universidade da Beira Interior, Portugal
"Human Bocavirus infection in children with Respiratory tract Infection" (TESE/DISSERTAÇÃO)
17
2002/09 - 2007/09
Concluído
Bioquímica (Licenciatura)
Especialização em Bioquímica
Universidade da Beira Interior, Portugal
"Role between serum concentrations of homocysteine, steroid hormones and vitamins B and mutations in 5,10-methylenetetrahydrofolate reductase gene, in association to Alzheimer's type dementia " (TESE/DISSERTAÇÃO)
14
Percurso profissional

Ciência

Categoria Profissional
Instituição de acolhimento
Empregador
2020/03/01 - Atual Investigador (Investigação) Center for Neurosciences and Cell Biology, University of Coimbra, Portugal
Biocant Associação de Transferência de Tecnologia, Portugal
2018/10 - 2020/02/28 Assistente de Investigação (carreira) (Investigação) Biocant Associação de Transferência de Tecnologia, Portugal
2016/09 - 2018/09 Assistente de Investigação (carreira) (Investigação) Princess Maxima Center, Center for Pediatric Oncology, Países Baixos
2011/01/14 - 2016/09 Assistente de Investigação (carreira) (Investigação) Erasmus MC Afdeling Kindergeneeskunde, Países Baixos
2010/02 - 2010/12 Estagiário de Investigação (Investigação) Amsterdam Universitair Medische Centra, Países Baixos

Outros

Categoria Profissional
Instituição de acolhimento
Empregador
2008/03 - 2010/01 Assistente de Farmácia Farmácia Central Sabugal, Guarda, Portugal
2007/10 - 2008/02 Assistente de Farmácia Farmácia Mousaco Torrão, Portugal
Projetos

Bolsa

Designação Financiadores
2020 - Atual Extracellular Vesicles in Diabetes
SFRH/BD/144119/2019
Bolseiro de Doutoramento
Center for Neurosciences and Cell Biology, University of Coimbra, Portugal
Associação para a Inovação e Desenvolvimento da FCT
2018 - Atual Towards personalized beta-cell mass imaging in type 2 Diabetes
95105008
Desenvolvimento técnico
Biocant Associação de Transferência de Tecnologia, Portugal
ZonMw

Outro

Designação Financiadores
2016 - 2018 High Throughput of epigenetic drug screening in high risk leukemias
-
Desenvolvimento técnico
Princess Maxima Center, Center for Pediatric Oncology, Países Baixos
Stichting Kinderen Kankervrij (KiKa)
2012 - 2016 Role of Bone Marrow niche Microenvironment in MLL-rearranged ALL using in vivo xenotransplantations models
KIKA.Project89
Desenvolvimento técnico
Erasmus MC, Países Baixos
Stichting Kinderen Kankervrij (KiKa)
2012 - 2016 Role of epigenetics in MLL rearranged infant ALL
-
Desenvolvimento técnico
Erasmus MC, Países Baixos
2011 - 2011/12 Unraveling drug resistance in Acute Lymphoblastic Leukemia in Infants
-
Desenvolvimento técnico
Erasmus MC, Países Baixos
Stichting Kinderen Kankervrij (KiKa)
2010 - 2010 Impact of p38 mitogen activated protein kinase inhibitor in pulmonary inflammation
-
Outra
Amsterdam Medical Center, Países Baixos
2010 - 2010 The potency of AMPK activation by AICAR to reduce inflammation in vitro and in vivo in a model of LTA-induced lung injury
-
Outra
Amsterdam Medical Center, Países Baixos
2007 - 2008 Detection of Human Bocavirus in children with Respiratory Infection
Master project
Outra
Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal
2006 - 2007 Serum homocysteine: interplay with other circulating and genetic factors in association to Alzheimer's type dementia
Projecto de Licenciatura
Outra
Universidade da Beira Interior Centro de Investigação em Ciências da Saúde, Portugal
Produções

Publicações

Artigo em revista
  1. Mark Kerstjens; Patricia Garrido Castro; Sandra S. Pinhanços; Pauline Schneider; Priscilla Wander; Rob Pieters; Ronald W. Stam. "Irinotecan Induces Disease Remission in Xenograft Mouse Models of Pediatric MLL-Rearranged Acute Lymphoblastic Leukemia". Biomedicines (2021): https://doi.org/10.3390/biomedicines9070711.
    10.3390/biomedicines9070711
  2. Priscilla Wander; Susan T.C.J.M. Arentsen-Peters; Sandra S. Pinhan¿os; Bianca Koopmans; M.Emmy M. Dolman; Rijndert Ariese; Frank L. Bos; et al. "High-throughput drug screening reveals Pyrvinium pamoate as effective candidate against pediatric MLL-rearranged acute myeloid leukemia". Translational Oncology (2021): https://doi.org/10.1016/j.tranon.2021.101048.
    10.1016/j.tranon.2021.101048
  3. Pinhanços, SS or Pinhanços, SM. "Decitabine mildly attenuates MLL -rearranged acute lymphoblastic leukemia in vivo, and represents a poor chemo-sensitizer". eJHaem (2020): http://dx.doi.org/10.1002/jha2.81.
    10.1002/jha2.81
  4. Pinhanços, SS or Pinhanços, SM. "Preclinical efficacy of gemcitabine in MLL-rearranged infant acute lymphoblastic leukemia". Leukemia (2020): http://dx.doi.org/10.1038/s41375-020-0895-9.
    10.1038/s41375-020-0895-9
  5. Garrido Castro P; van Roon EHJ; Pinhanços SS; Trentin L; Schneider P; Kerstjens M; Te Kronnie G; et al. "The HDAC inhibitor panobinostat (LBH589) exerts in vivo anti-leukaemic activity against MLL-rearranged acute lymphoblastic leukaemia and involves the RNF20/RNF40/WAC-H2B ubiquitination axis.". Leukemia (2018): http://europepmc.org/abstract/med/28690313.
    10.1038/leu.2017.216
  6. Kerstjens M; Pinhancos SS; Garrido Castro P; Schneider P; Wander P; Pieters R; Stam RW. "Trametinib inhibits RAS-mutant MLL-rearranged acute lymphoblastic leukemia at specific niche sites and reduces ERK phosphorylation in vivo.". Haematologica (2018): http://europepmc.org/abstract/med/29419436.
    10.3324/haematol.2017.174060
  7. Kerstjens M; Driessen EM; Willekes M; Pinhanços SS; Schneider P; Pieters R; Stam RW. "MEK inhibition is a promising therapeutic strategy for MLL-rearranged infant acute lymphoblastic leukemia patients carrying RAS mutations.". Oncotarget (2017): http://europepmc.org/abstract/med/27588400.
    10.18632/oncotarget.11730
  8. Driessen EM; Pinhanços SS; Schneider P; de Lorenzo P; Valsecchi MG; Pieters R; Stam RW. "Versican expression is an adverse prognostic factor in MLL-rearranged infant acute lymphoblastic leukaemia.". European journal of cancer (Oxford, England : 1990) (2016): http://europepmc.org/abstract/med/26901613.
    10.1016/j.ejca.2015.12.031
  9. Spijkers-Hagelstein JA; Schneider P; Pinhanços SM; Garrido Castro P; Pieters R; Stam RW. "Glucocorticoid sensitisation in Mixed Lineage Leukaemia-rearranged acute lymphoblastic leukaemia by the pan-BCL-2 family inhibitors gossypol and AT-101.". European journal of cancer (Oxford, England : 1990) (2014): http://europepmc.org/abstract/med/24703900.
    10.1016/j.ejca.2014.03.011
  10. Spijkers-Hagelstein JA; Pinhanços SS; Schneider P; Pieters R; Stam RW. "Chemical genomic screening identifies LY294002 as a modulator of glucocorticoid resistance in MLL-rearranged infant ALL.". Leukemia (2014): http://europepmc.org/abstract/med/23958920.
    10.1038/leu.2013.245
  11. Hoogendijk AJ; Pinhanços SS; van der Poll T; Wieland CW. "Intrapulmonary administration of a p38 mitogen activated protein kinase inhibitor partially prevents pulmonary inflammation.". Immunobiology (2013): http://europepmc.org/abstract/med/22727776.
    10.1016/j.imbio.2012.05.027
  12. Spijkers-Hagelstein JA; Mimoso Pinhanços S; Schneider P; Pieters R; Stam RW. "Src kinase-induced phosphorylation of annexin A2 mediates glucocorticoid resistance in MLL-rearranged infant acute lymphoblastic leukemia.". Leukemia (2013): http://europepmc.org/abstract/med/23334362.
    10.1038/leu.2012.372
  13. Hoogendijk AJ; Pinhanços SS; van der Poll T; Wieland CW. "AMP-activated protein kinase activation by 5-aminoimidazole-4-carbox-amide-1-ß-D-ribofuranoside (AICAR) reduces lipoteichoic acid-induced lung inflammation.". The Journal of biological chemistry (2013): http://europepmc.org/abstract/med/23322781.
    10.1074/jbc.m112.413138
  14. Cascalheira JF; João SS; Pinhanços SS; Castro R; Palmeira M; Almeida S; Faria MC; Domingues FC. "Serum homocysteine: interplay with other circulating and genetic factors in association to Alzheimer's type dementia.". Clinical biochemistry (2009): http://europepmc.org/abstract/med/19232336.
    10.1016/j.clinbiochem.2009.02.006
Poster em conferência
  1. Pinhanços, SS or Pinhanços, SM. "Selective Inhibition of Class II HDAC Isoforms 4 and 5 Provides a Promising Therapeutic Intervention for MLL-Rearranged Acute Lymphoblastic Leukemia in Infants". 2021.
    10.1182/blood-2021-147164
Tese / Dissertação
  1. Domingues, Fernanda da Conceição; Almeida, Sofia Isabel de Aguiar de; Pinhanços, Sandra Sofia Mimoso. "Detecção do bocavírus humano em crianças com infecção respiratória". Mestrado, 2008. http://hdl.handle.net/10400.6/2492.

Outros

Outra produção
  1. Cascalheira, Jose F.; Joao, Sara S.; Pinhancos, Sandra S.; Castro, Rita; Palmeira, Manuela; Almeida, Sofia; Faria, Maria C.; Domingues, Fernanda C.. 2009. Serum homocysteine. Objectives: To study the interplay between serum concentrations of homocysteine, steroid hormones and vitamins B and mutations in 5,10-methylenetetrahydrofolate reductase (MTHFR) gene, in association to Alzheimer's type dementia (ATD). Design and methods: Case-control study including 19 individuals diagnosed with ATD and 36 healthy controls. Serum concentrations of the analytes were determined and. http://hdl.handle.net/10451/21475.
    http://dx.doi.org/10.1016/j.clinbiochem.2009.02.006
Atividades

Participação em evento

Descrição da atividade
Tipo de evento
Nome do evento
Instituição / Organização
2020/09/19 - Atual 2nd Retreat of CIBB's Innovative Therapies Area. zoom meeting 19/09/2020
Conferência
2nd Retreat of CIBB's Innovative Therapies Area.
2021/07/14 - 2021/07/14 Training in Health and Safety at Work "SST-Prevenção da Transmissão da Infeção"
Seminário
"SST-Prevenção da Transmissão da Infeção"
Center for Neurosciences and Cell Biology, University of Coimbra, Portugal
2021/06/11 - 2021/06/11 1st RESETaging Conference, June 11th, 2021
Conferência
1st RESETaging Conference
Center for Neurosciences and Cell Biology, University of Coimbra, Portugal
2021/04/19 - 2021/04/23 PDBEB Courses 2020/2021 - Advanced Therapies
Outro
Advanced Therapies
Center for Neurosciences and Cell Biology, University of Coimbra, Portugal
2021/02/01 - 2021/02/05 PDBEB Courses 2020/2021 - High-Throughput Screening for Target and Drug Discovery
Outro
High-Throughput Screening for Target and Drug Discovery
Center for Neurosciences and Cell Biology, University of Coimbra, Portugal
2020/12/18 - 2020/12/18 First Workshop of the Portuguese Network on Extracellular Vesicles: EVs in Health and Disease Online Even
Conferência
First Workshop of the Portuguese Network on Extracellular Vesicles: EVs in Health and Disease
Universidade do Porto Instituto de Investigação e Inovação em Saúde, Portugal
2020/11/18 - 2020/11/18 1st Retreat Metabolism Aging and Disease area
Outro
1st Retreat Metabolism Aging and Disease area
Center for Neurosciences and Cell Biology, University of Coimbra, Portugal
2020/09/20 - 2020/09/30 ESCI Virtual Meeting 2020
Conferência
ESCI Virtual Meeting 2020
2019/06/28 - 2019/06/29 “Ageing: Models, mechanisms and therapies” conference.
Conferência
“Ageing: Models, mechanisms and therapies”
Center for Neurosciences and Cell Biology, University of Coimbra, Portugal
2017/06/22 - 2017/06/25 22nd Congress of European Hematology Association (EHA), Madrid, Spain.
Congresso
Congress of European Hematology Association